Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial

BACKGROUND: There is no study regarding the use of SOF/LDP in treatment of COVID-19. OBJECTIVES: In this study, the efficacy and safety of SOF/LDP were assessed in treatment of patients with mild to moderate COVID-19. METHODS: Among an open-label randomized clinical trial, 82 patients with mild to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nourian, Anahid, Khalili, Hossein, Ahmadinejad, Zahra, Emadi Kouchak, Hamid, Jafari, Sirous, Dehghan Manshadi, Sayed Ali, Rasolinejad, Mehrnaz, Kebriaeezadeh, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Original Investigations/Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927527/
https://www.ncbi.nlm.nih.gov/pubmed/33525212
http://dx.doi.org/10.23750/abm.v91i4.10877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927527/
https://www.ncbi.nlm.nih.gov/pubmed/33525212
http://dx.doi.org/10.23750/abm.v91i4.10877

Ejemplares similares